Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Race Oncology Ltd. ( (AU:RAC) ) just unveiled an announcement.
Race Oncology Ltd has announced the issuance of 2,350,843 unquoted equity securities under an employee incentive scheme, with these options set to expire on June 30, 2029, at an exercise price of $1.67. This move is part of the company’s strategy to incentivize employees, potentially impacting its operational dynamics and aligning employee interests with long-term company goals.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development of cancer therapies.
Average Trading Volume: 110,294
Technical Sentiment Signal: Sell
Current Market Cap: A$198.1M
See more insights into RAC stock on TipRanks’ Stock Analysis page.